Shoulder Arthritis, Shoulder Arthropathy Associated With Other Conditions
Conditions
Keywords
prino, total shoulder arthroplasty, wound closure
Brief summary
The objective is to compare two types of wound closure after total shoulder arthroplasty to determine which closure is faster, and subsequently if there are different outcomes between the two types of closures. The objective of this study is to compare two types of wound closure after total shoulder arthroplasty procedures. A single fellowship trained shoulder surgeon will perform all procedures. It is hypothesized that participants who undergo an 2-Octyl Cyanoacrylate (OCA) mesh closure will have a faster closure time, lower cost, non-inferior complication rate, and non-inferior satisfaction scores with respect postoperative follow up and scar appearance. Participants in the OCA mesh cohort will be compared to participants who have a closure with a running monocryl suture and dermabond. This investigation seeks to determine if OCA closure mesh closure is non-inferior to monocryl suture and dermabond in terms of operative time, cost, complications, and aesthetic appearance. If the hypothesis is confirmed, this study will suggest that a OCA mesh closure may be used for total shoulder arthroplasty surgeries as an alternative to current conventional closures and may provide a cost benefit.
Interventions
2-Octyl Cyanoacrylate and a mesh will be applied to final closure of wounds after undergoing a Total Shoulder Arthroplasty
Incisions will be closed with 2-Octyl Cyanoacrylate after undergoing a Total shoulder arthroplasty
Sponsors
Study design
Masking description
Sealed envelop determining which arm the participant is assigned to
Intervention model description
\* Prospective Randomized Design o After determining a participant's eligibility for inclusion, participant will be randomized to the OCA mesh group or monocryl with dermabond group. After surgery, both groups will be seen at the 2 week, 6 week, and 3 month appointments
Eligibility
Inclusion criteria
* Total shoulder arthroplasty * Reverse total shoulder arthroplasty * Age 18-100 * Single Surgeon
Exclusion criteria
* Previous shoulder surgery * Known wound healing complications * DM, chronic steroid use, vascular insufficiency, morbid obesity (BMI\>40), ESRD, family hx of pathologic scars * Patients on blood thinners (ASA 81mg ok) * Connective tissue disease * Allergy to skin adhesive * Mentally unable to complete questionnaires * Previous wound over planned incision
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time for Incision Closure | During surgery (approximately 40 minutes) | A stopwatch will be used to measure the time it takes for the incision to be closed. When the surgical implants are in place and irrigation is complete, the surgeon will announce that he will start the closure and a nurse will start the stopwatch to measure how long it takes for the surgeon to close the incision. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Wound Appearance | At each follow up visit up to 3 months after surgery | The surgeon and participant will fill out the Patient and Observer Scar Assessment Scale (POSAS). This is a survey used to assess the participant and the surgeons opinion of the appearance of the wound. The Patient and Observer Scar Assessment Scale (POSAS) is a questionnaire that was developed to assess scar quality. It consists of two separate six-item scales (Observer Scale and Patient Scale), both of which are scored on a 10-point rating scale. Each questionnaire consists of 7 questions, each graded 1 through 10. The minimum score is 7 (most like normal skin) and the maximum score is 70 (very different from normal skin). The observer is the surgeon. The observer and patient scores can then be added together to determine the collective score. |
| Dehiscence | At each follow up visit up to 3 months after surgery | The wound will be assessed for dehiscence (incision opening) which will be recorded as a yes or no. A dehiscence is defined as exposure of the underlying subcutaneous fat secondary to failure of the epidermal healing and may be accompanied by persistent wound drainage. It will be assessed by the length of the opening in centimeters and then normalized against the length of the entire incision. Furthermore, the number of wounds that open will be reported |
| Wound Drainage | At first post operative visit | Dressing for each participant after surgery will be regulated and changed by the surgeon at the first post op visit. Drainage will be measured by outlining the drainage on gauze onto graph paper and measuring the area as previously validated in prior studies |
| Cost of Closure | Immediately post surgery | Cost of closure will be assessed by the cost of the time in the operating room and the cost of materials used to close the incision |
| Deep Wound Infection | At each follow up visit up to 3 months after surgery | Number of deep wound infections found will be reported |
| Number of Wounds That Require Post Operative Intervention | At each follow up visit up to 3 months after surgery | Will report the number of wounds that require post operative intervention |
| Superficial Infection | At each follow up visit up to 3 months after surgery | Number of wounds with superficial skin infections will be reported |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| 2-Octyl Cyanoacrylate and Mesh The wound will be closed with 2-Octyl Cyanoacrylate and a mesh
2-Octyl Cyanoacrylate and Mesh: 2-Octyl Cyanoacrylate and a mesh will be applied to final closure of wounds after undergoing a Total Shoulder Arthroplasty | 1 |
| 2-Octyl Cyanoacrylate The wound will be closed with just 2-Octyl Cyanoacrylate
2-Octyl Cyanoacrylate: Incisions will be closed with 2-Octyl Cyanoacrylate after undergoing a Total shoulder arthroplasty | 0 |
| Total | 1 |
Baseline characteristics
| Characteristic | 2-Octyl Cyanoacrylate and Mesh | Total |
|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 0 Participants | 0 Participants |
| Race and Ethnicity Not Collected | — | 0 Participants |
| Region of Enrollment United States | 1 participants | 1 participants |
| Sex: Female, Male Female | — | 0 Participants |
| Sex: Female, Male Male | — | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Time for Incision Closure
A stopwatch will be used to measure the time it takes for the incision to be closed. When the surgical implants are in place and irrigation is complete, the surgeon will announce that he will start the closure and a nurse will start the stopwatch to measure how long it takes for the surgeon to close the incision.
Time frame: During surgery (approximately 40 minutes)
Population: Data was not collected/aggregated and therefore not analyzed.
Cost of Closure
Cost of closure will be assessed by the cost of the time in the operating room and the cost of materials used to close the incision
Time frame: Immediately post surgery
Population: Data was not collected/aggregated and therefore not analyzed.
Deep Wound Infection
Number of deep wound infections found will be reported
Time frame: At each follow up visit up to 3 months after surgery
Population: Data was not collected/aggregated and therefore not analyzed.
Dehiscence
The wound will be assessed for dehiscence (incision opening) which will be recorded as a yes or no. A dehiscence is defined as exposure of the underlying subcutaneous fat secondary to failure of the epidermal healing and may be accompanied by persistent wound drainage. It will be assessed by the length of the opening in centimeters and then normalized against the length of the entire incision. Furthermore, the number of wounds that open will be reported
Time frame: At each follow up visit up to 3 months after surgery
Population: Data was not collected/aggregated and therefore not analyzed.
Number of Wounds That Require Post Operative Intervention
Will report the number of wounds that require post operative intervention
Time frame: At each follow up visit up to 3 months after surgery
Population: Data was not collected/aggregated and therefore not analyzed.
Superficial Infection
Number of wounds with superficial skin infections will be reported
Time frame: At each follow up visit up to 3 months after surgery
Population: Data was not collected/aggregated and therefore not analyzed.
Wound Appearance
The surgeon and participant will fill out the Patient and Observer Scar Assessment Scale (POSAS). This is a survey used to assess the participant and the surgeons opinion of the appearance of the wound. The Patient and Observer Scar Assessment Scale (POSAS) is a questionnaire that was developed to assess scar quality. It consists of two separate six-item scales (Observer Scale and Patient Scale), both of which are scored on a 10-point rating scale. Each questionnaire consists of 7 questions, each graded 1 through 10. The minimum score is 7 (most like normal skin) and the maximum score is 70 (very different from normal skin). The observer is the surgeon. The observer and patient scores can then be added together to determine the collective score.
Time frame: At each follow up visit up to 3 months after surgery
Population: Data was not collected/aggregated and therefore not analyzed.
Wound Drainage
Dressing for each participant after surgery will be regulated and changed by the surgeon at the first post op visit. Drainage will be measured by outlining the drainage on gauze onto graph paper and measuring the area as previously validated in prior studies
Time frame: At first post operative visit
Population: Data was not collected/aggregated and therefore not analyzed.